Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person prenalterol [extracellular region]

Class:Id	ChemicalDrug:9611741
_displayName	prenalterol [extracellular region]
_timestamp	2018-12-12 00:29:45
compartment	[Compartment:984] extracellular region
created	[InstanceEdit:9611731] Jassal, Bijay, 2018-06-19
crossReference	[DatabaseIdentifier:9627978] ChEBI:8391
disease	[Disease:9608422] congestive heart failure
literatureReference	[LiteratureReference:9611686] Prenalterol, an oral beta-1 adrenoceptor agonist, in the treatment of chronic heart failure [LiteratureReference:9611727] Prenalterol: a partial beta 1-adrenoceptor agonist or a beta-blocker with intrinsic activity?
modified	[InstanceEdit:9613282] Jassal, Bijay, 2018-07-13 [InstanceEdit:9616750] Weiser, JD [InstanceEdit:9616752] Shorser, Solomon, 2018-08-13 [InstanceEdit:9619953] Wu, G, 2018-09-19 [InstanceEdit:9625631] Jassal, Bijay, 2018-10-22 [InstanceEdit:9627975] Wu, G, 2018-11-05 [InstanceEdit:9631716] Wu, G, 2018-12-12
name	prenalterol
referenceEntity	[ReferenceTherapeutic:9611714] prenalterol [Guide to Pharmacology:537]
stableIdentifier	[StableIdentifier:9611757] R-ALL-9611741.2
(hasMember)	[DefinedSet:9611687] β1-agonists [extracellular region] [Homo sapiens]
[Change default viewing format]

No pathways have been reviewed or authored by prenalterol [extracellular region] (9611741)